메뉴 건너뛰기




Volumn 120, Issue 1-3, 2001, Pages 59-66

Assessment of biotechnology products for therapeutic use

Author keywords

Biotechnology; Pharmaceutical; Safety assessment

Indexed keywords

BLOOD CLOTTING FACTOR; CYTOKINE; DNA VACCINE; ENZYME; GROWTH FACTOR; HORMONE; MONOCLONAL ANTIBODY; RECEPTOR; RIBOZYME; VACCINE;

EID: 0035977920     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(01)00310-1     Document Type: Conference Paper
Times cited : (19)

References (8)
  • 1
    • 0034631196 scopus 로고    scopus 로고
    • Regulatory issues: Department of Health and Human Services Recombinant DNA Advisory Committee, National Institute of Health, minutes of meeting, 14 June 1999
    • (2000) Hum. Gene Ther. , vol.11 , pp. 1369-1382
  • 8
    • 0033916950 scopus 로고    scopus 로고
    • Using an analagous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanised anti-TNFα monoclonal antibody
    • (2000) Hum. Exp. Toxicol. , vol.19 , pp. 226-228
    • Treacy, G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.